THNR vs. SPAQ

Last updated Jun 3, 2026

THNR (Amplify Weight Loss Drug & Treatment ETF) and SPAQ (Horizon Kinetics SPAC Active ETF) are both Health & Biotech Equities funds. THNR is passively managed, while SPAQ is actively managed. Over the past year, THNR returned 9.10% vs 4.69% for SPAQ. At a 0.05 correlation, their price movements are largely independent. THNR charges 0.59%/yr vs 0.85%/yr for SPAQ.

Performance

THNR vs. SPAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and Horizon Kinetics SPAC Active ETF (SPAQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, THNR achieves a -5.20% return, which is significantly lower than SPAQ's 2.81% return.

THNR

• 1D: -1.47%
• 1M: -2.91%
• YTD: -5.20%
• 6M: -3.73%
• 1Y: 9.10%
• 3Y*: —
• 5Y*: —
• 10Y*: —

SPAQ

• 1D: -0.01%
• 1M: 1.29%
• YTD: 2.81%
• 6M: 1.62%
• 1Y: 4.69%
• 3Y*: 5.87%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. SPAQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024
THNR Amplify Weight Loss Drug & Treatment ETF	-5.20%	13.65%	-10.36%
SPAQ Horizon Kinetics SPAC Active ETF	2.81%	7.35%	2.67%

Correlation

The correlation between THNR and SPAQ is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (All Time) Calculated using the full available price history since May 22, 2024	0.05

THNR vs. SPAQ - Sectors Allocation Comparison

Sectors	THNR	SPAQ
Healthcare	97.7%	-
Financial Services	0.9%	91.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	0.1%
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

THNR vs. SPAQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR

THNR Risk / Return Rank: 16
THNR Sharpe Ratio Rank: 15
THNR Sortino Ratio Rank: 16
THNR Omega Ratio Rank: 15
THNR Calmar Ratio Rank: 18
THNR Martin Ratio Rank: 17

SPAQ

SPAQ Risk / Return Rank: 19
SPAQ Sharpe Ratio Rank: 17
SPAQ Sortino Ratio Rank: 16
SPAQ Omega Ratio Rank: 19
SPAQ Calmar Ratio Rank: 20
SPAQ Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. SPAQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and Horizon Kinetics SPAC Active ETF (SPAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	THNR	SPAQ	Difference
Sharpe ratio Return per unit of total volatility	0.48	0.54	-0.06
Sortino ratio Return per unit of downside risk	0.81	0.80	+0.02
Omega ratio Gain probability vs. loss probability	1.10	1.12	-0.02
Calmar ratio Return relative to maximum drawdown	0.76	0.90	-0.14
Martin ratio Return relative to average drawdown	1.75	3.23	-1.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

THNR vs. SPAQ - Sharpe Ratio Comparison

The current THNR Sharpe Ratio is 0.48, which is comparable to the SPAQ Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of THNR and SPAQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	THNR	SPAQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.48	0.54	-0.06
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.86	-0.95

Drawdowns

THNR vs. SPAQ - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, which is greater than SPAQ's maximum drawdown of -5.30%. Use the drawdown chart below to compare losses from any high point for THNR and SPAQ.

Drawdown Indicators

	THNR	SPAQ	Difference
Max Drawdown Largest peak-to-trough decline	-32.51%	-5.30%	-27.21%
Max Drawdown (1Y) Largest decline over 1 year	-12.06%	-5.30%	-6.76%
Max Drawdown (3Y) Largest decline over 3 years	—	-5.30%	—
Current Drawdown Current decline from peak	-13.00%	-0.01%	-12.99%
Average Drawdown Average peak-to-trough decline	-12.24%	-0.54%	-11.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.26%	1.47%	+3.79%

Volatility

THNR vs. SPAQ - Volatility Comparison

Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.16% compared to Horizon Kinetics SPAC Active ETF (SPAQ) at 1.97%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than SPAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	THNR	SPAQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.16%	1.97%	+3.19%
Volatility (6M) Calculated over the trailing 6-month period	13.55%	5.01%	+8.54%
Volatility (1Y) Calculated over the trailing 1-year period	19.15%	8.80%	+10.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.37%	7.00%	+12.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.37%	7.00%	+12.37%

THNR vs. SPAQ - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is lower than SPAQ's 0.85% expense ratio.

Dividends

THNR vs. SPAQ - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.73%, less than SPAQ's 16.23% yield.

Position	TTM	2025	2024	2023
SPAQ Horizon Kinetics SPAC Active ETF	16.23%	16.69%	3.00%	2.60%
THNR Amplify Weight Loss Drug & Treatment ETF	1.73%	1.64%	0.98%	0.00%

Frequently Asked Questions

Can I hold both THNR and SPAQ in my portfolio?

THNR and SPAQ have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, THNR or SPAQ?

THNR has higher volatility (5.16%) compared to SPAQ (1.97%). In terms of maximum drawdown, THNR dropped -32.51% vs SPAQ's -5.30%.

Which ETF is better, THNR or SPAQ?

On 1-year performance, THNR leads with 9.10% vs 4.69% for SPAQ. On fees, THNR is cheaper at 0.59% per year. On volatility, SPAQ has been the lower-risk option at 1.97%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, THNR or SPAQ?

Over the 1-year period, THNR has performed better with a 9.10% return vs 4.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, THNR or SPAQ?

THNR is cheaper with a 0.59% expense ratio, compared with 0.85% for SPAQ.

Which ETF pays a higher dividend yield, THNR or SPAQ?

SPAQ has the higher dividend yield at 16.23%, compared with 1.73% for THNR.

What is the main difference between THNR and SPAQ?

They also come from different issuers: Amplify and Horizon. Their fees differ too: 0.59% for THNR and 0.85% for SPAQ.

Which has better risk-adjusted returns?

SPAQ currently has the higher Sharpe Ratio (0.54 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.